Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Rating of “Hold” from Analysts

Teladoc Health, Inc. (NYSE:TDOC) has been given an average recommendation of “Hold” by the nineteen ratings firms that are presently covering the firm, MarketBeat reports. Twelve equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $9.71.

Several research analysts have recently commented on the company. The Goldman Sachs Group reduced their price target on Teladoc Health from $13.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, May 1st. Piper Sandler reduced their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th. Jefferies Financial Group reduced their price objective on shares of Teladoc Health from $10.00 to $8.00 and set a “hold” rating on the stock in a report on Monday, April 21st. Citigroup reduced their price objective on shares of Teladoc Health from $11.00 to $8.75 and set a “neutral” rating on the stock in a report on Friday, April 25th. Finally, Oppenheimer reduced their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Friday, January 24th.

Teladoc Health Stock Up 0.6%

NYSE TDOC opened at $7.12 on Wednesday. Teladoc Health has a 52 week low of $6.35 and a 52 week high of $15.21. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The business’s fifty day simple moving average is $7.75 and its 200-day simple moving average is $9.42. The firm has a market cap of $1.25 billion, a PE ratio of -1.23 and a beta of 1.82.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. As a group, equities analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Adam C. Vandervoort sold 11,011 shares of the business’s stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the transaction, the insider now directly owns 64,308 shares of the company’s stock, valued at approximately $541,473.36. The trade was a 14.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.58% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently made changes to their positions in TDOC. Versant Capital Management Inc grew its position in shares of Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after buying an additional 2,441 shares in the last quarter. Smith Anglin Financial LLC acquired a new position in shares of Teladoc Health during the fourth quarter worth about $108,000. Arkadios Wealth Advisors acquired a new position in Teladoc Health in the fourth quarter valued at approximately $115,000. Nisa Investment Advisors LLC boosted its holdings in Teladoc Health by 20,936.8% in the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock valued at $3,874,000 after purchasing an additional 424,180 shares in the last quarter. Finally, Westside Investment Management Inc. boosted its holdings in Teladoc Health by 43.8% in the fourth quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock valued at $84,000 after purchasing an additional 2,800 shares in the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.